Search results
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? | The Motley Fool
The Motley Fool· 3 days agoCathie Wood is buying the dip on two biotechs in particular, so for her, the answer to that question...
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 5 days agoOn Sunday, Intellia Therapeutics (Nasdaq: NTLA) said that its experimental gene-editing treatment...
In Central Florida, scientists battle citrus disease with genetic engineering
WLRN Miami· 1 day agoOne March morning, more than eighty years after his family first started growing oranges in DeLeon...
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Zacks via Yahoo Finance· 1 day agoRepare (RPTX) rises 14% as the FDA grants Fast Track designation to its investigational...
AI plus gene editing promises to shift biotech into high gear
San Francisco Chronicle· 1 day agoSince then, science and technology have progressed so much that artificial intelligence has learned to compose DNA, and with genetically modified bacteria, scientists are on their way to designing ...
Gene-Edited Salad Greens Are Coming to US Stores This Fall
Wired News· 7 days agoLast year, startup Pairwise started selling the first food in the US made with Crispr technology: a...
Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
The Good News You Might Have Missed, By Angus Hervey | DailyGood
DailyGood· 7 hours agoEverywhere we look, there are reports of decline. Well, your answer to that question probably...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool via Yahoo Finance· 23 hours agoHowever, the gene-editing stock is moving higher this week. Intellia investors got a boost this week...